CompletedNot Applicable

Post Marketing Surveillance Study of Dysport

France783 participantsStarted 2004-10

Plain-language summary

The purpose of this study is to provide further information regarding the risks and benefits of Dysport in marketed indications.

Who can participate

Age range2 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * adult or child over the age of 2 years * scheduled to receive Dysport as per their normal treatment practice, and in conformance with their country's Summary of Product Characteristics Exclusion Criteria: * history of hypersensitivity to Dysport or drugs with a similar chemical structure * treatment with any other investigational drug within the last 30 days before survey entry

What they're measuring

- assessment of efficacy as assessed by treating physician at scheduled follow up visit

- data on adverse events since treatment with Dysport

Trial details

NCT IDNCT00210431

SponsorIpsen

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

View on ClinicalTrials.gov More Blepharospasm trials